RK

Rama Kant Katiyar

Director Director DIN 01853582
DIN 01853582 First appointment Nov 1998 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Nov 1998
Shareholding value Locked Premium profile

About Rama Kant Katiyar

Rama Kant Katiyar has 27 years in corporate governance. Formerly with 1 company, such as Daisy Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 01853582
Primary Designation Director
First Appointment 06 Nov 1998
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

Company Designation Appointment Founded Status
Daisy Pharma Private Limited U24231UP1998PTC023966
Director 06 Nov 1998 1998 Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Daisy Pharma Private Limited
Premium access

Shareholding and investment profile for Rama Kant Katiyar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rama Kant Katiyar

Rama Kant Katiyar has 27 years in corporate governance. Formerly with 1 company, such as Daisy Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

Rama Kant Katiyar is associated with 0 companies as a director.

Rama Kant Katiyar has expertise in General Business.

Rama Kant Katiyar has 27 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available